
Nate Silver @NateSilver538
The vaccine companies were—unavoidably—doing a lot of educated guesswork with their dosing regimens. Which is why regulators ought to be relatively willing to adjust to new evidence rather than treating whatever protocols were chosen in clinical trials as the word of God. — PolitiTweet.org
Eric Topol @EricTopol
Interesting to read @Pfizer's chief scientific officer addressing dose selection of their vaccine, push for booster… https://t.co/hP6XIQ3wnA